JP2018501215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501215A5 JP2018501215A5 JP2017529357A JP2017529357A JP2018501215A5 JP 2018501215 A5 JP2018501215 A5 JP 2018501215A5 JP 2017529357 A JP2017529357 A JP 2017529357A JP 2017529357 A JP2017529357 A JP 2017529357A JP 2018501215 A5 JP2018501215 A5 JP 2018501215A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- salt according
- salt
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229950006238 nadide Drugs 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462086844P | 2014-12-03 | 2014-12-03 | |
| US62/086,844 | 2014-12-03 | ||
| PCT/IB2015/058965 WO2016087975A1 (en) | 2014-12-03 | 2015-11-19 | Cd38 inhibitors and methods of treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501215A JP2018501215A (ja) | 2018-01-18 |
| JP2018501215A5 true JP2018501215A5 (US07981874-20110719-C00313.png) | 2018-11-01 |
| JP6550132B2 JP6550132B2 (ja) | 2019-07-24 |
Family
ID=54708091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017529357A Active JP6550132B2 (ja) | 2014-12-03 | 2015-11-19 | Ｃｄ３８阻害剤及び治療の方法 |
Country Status (11)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020504086A (ja) * | 2016-11-23 | 2020-02-06 | アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | ヒストン脱アセチル化酵素阻害剤とｃｄ３８阻害剤とを含む医薬組み合わせ物及びその使用方法 |
| US20200345725A1 (en) | 2019-01-11 | 2020-11-05 | Omeros Corporation | Methods and Compositions for Treating Cancer |
| JP2022542396A (ja) * | 2019-07-31 | 2022-10-03 | ライボン・セラピューティクス・インコーポレイテッド | Ｃｄ３８の阻害剤としてのヘテロ二環式アミド |
| US20230025807A1 (en) | 2019-10-30 | 2023-01-26 | Mitobridge Inc. | Cd38 inhibitors |
| IL297128A (en) * | 2020-04-07 | 2022-12-01 | Mitobridge Inc | cd38 inhibitors |
| WO2022165114A1 (en) | 2021-01-29 | 2022-08-04 | Ribon Therapeutics, Inc. | Quinolines and azaquinolines as inhibitors of cd38 |
| KR20240001709A (ko) * | 2021-04-30 | 2024-01-03 | 난징 이뮤노파지 바이오테크 코., 엘티디. | 화합물 및 cd38 억제제로서의 용도 |
| CN117813296A (zh) * | 2021-07-12 | 2024-04-02 | 赛特凯恩蒂克公司 | Cd38调节剂和其使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1370139A4 (en) * | 2001-01-04 | 2010-09-22 | Einstein Coll Med | INHIBITORS OF ADP-RIBOSYL TRANSFERASES, CYCLASES, AND HYDROLASES, AND USES THEREOF |
| US7022680B2 (en) | 2002-05-30 | 2006-04-04 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases |
| EP2801573A1 (en) * | 2013-05-09 | 2014-11-12 | Sanofi | Hydantoine derivatives as CD38 inhibitors |
-
2015
- 2015-11-19 KR KR1020177018180A patent/KR20170090478A/ko unknown
- 2015-11-19 CN CN201580073761.2A patent/CN107428733A/zh active Pending
- 2015-11-19 EP EP15801951.3A patent/EP3227275B1/en active Active
- 2015-11-19 WO PCT/IB2015/058965 patent/WO2016087975A1/en active Application Filing
- 2015-11-19 RU RU2017121002A patent/RU2017121002A/ru not_active Application Discontinuation
- 2015-11-19 JP JP2017529357A patent/JP6550132B2/ja active Active
- 2015-11-19 CA CA2969178A patent/CA2969178A1/en not_active Abandoned
- 2015-11-19 AU AU2015356721A patent/AU2015356721B2/en not_active Ceased
- 2015-11-19 US US15/529,120 patent/US9840496B2/en active Active
- 2015-11-19 ES ES15801951T patent/ES2717260T3/es active Active
- 2015-11-19 BR BR112017011642A patent/BR112017011642A2/pt not_active Application Discontinuation
